COP vs ENTA · P/E 19, rev $58.94B vs rev $65.3M
ConocoPhillips (COP) versus Enanta Pharmaceuticals Inc (ENTA) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. ENTA currently screens at market cap $328.0M.
Not investment advice. Open the COP and ENTA stock pages for the full models.
Not investment advice.